The Uromigos: EAU

Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news from the annual EAU Congress.

Episode 309: EAU 24 CheckMate-274 - OS for Adjuvant Nivolumab
Dr. Galsky describes the OS signal data from CheckMate-274 on adjuvant nivolumab for muscle-invasive bladder cancer.
Advertisement
Advertisement
Advertisement